Vyndaqel

Indicated For

cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM)

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get Vyndaqel (tafamidis meglumine) at Low or No Cost Vyndaqel (tafamidis meglumine) is a prescription medication used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a serious heart condition caused by abnormal protein buildup in the heart. This guide explains how the **Pfizer Patient Assistance Program (PAP)** can help eligible patients get Vyndaqel at little or no cost if you're uninsured or underinsured and meet income requirements.[1][2] ## About Vyndaqel and Why Assistance Matters **Vyndaqel** helps stabilize transthyretin proteins to reduce heart muscle damage and slow disease progression in adults with ATTR-CM. It's typically taken as oral capsules, often long-term, and can be expensive without insurance—thousands of dollars per month. The Pfizer PAP provides up to a **1-year supply** for eligible uninsured patients or **90 days** while applying for Medicaid, making it accessible for those facing financial hardship.[1][2][4] This program is ideal if high costs prevent you from starting or continuing treatment. Always consult your doctor about Vyndaqel and this program—it's not for everyone, and eligibility rules can change.[2] ## Who Qualifies? To qualify for free or low-cost Vyndaqel through Pfizer PAP: - Be **18 years or older** and reside in the U.S. or U.S. territory.[8] - Have a **valid U.S. prescription** from a licensed healthcare provider for outpatient use.[2] - Be **uninsured** or **underinsured** (e.g., denied coverage by insurer after appeal, or government-insured but unable to afford costs). **Commercially insured patients are not eligible**—a separate co-pay program exists for them.[2][3][7] - Meet **income limits**, typically up to **500% of the Federal Poverty Level (FPL)** based on household size (exact thresholds vary; see table below).[8] - Have an **FDA-approved diagnosis** like ATTR-CM.[3] - For Medicare Part D patients: Enroll in the Medicare Prescription Payment Plan and attest inability to afford costs.[7] **Note:** Pfizer does not require U.S. citizenship proof but needs a U.S. address. Some patients may need to exhaust other assistance (e.g., Medicaid application) first.[2] ## Income Eligibility Breakdown Income eligibility is based on pre-tax household income at or below **500% FPL**. Use proof like tax returns, W-2s, or pay stubs. Here's a table for 2026 FPL guidelines (approximate; confirm current levels at application): | Household Size | 100% FPL | 500% FPL (Max Eligible Income) | |---------------|----------|-------------------------------| | 1 (Individual) | $15,060 | $75,300 | | 2 (Couple) | $20,440 | $102,200 | | 3 | $25,820 | $129,100 | | 4 | $31,200 | $156,000 | | +1 Member | +$5,380 | +$26,900 | *Add $5,380 per additional person for 100% FPL; multiply by 5 for 500%.*[8] Exact eligibility assessed during application; include all household income sources.[4][10] ## Insurance Requirements - **Uninsured**: Fully eligible if other criteria met.[2] - **Underinsured/Government Insurance** (Medicaid, Medicare Part D): Eligible if you can't afford costs post-prior authorization (PA) or denial appeal. Medicare patients must join the Payment Plan.[7][8] - **Commercially Insured**: Not eligible for PAP; use Pfizer's co-pay assistance instead.[2][3] - Submit insurance cards (front/back) and details like co-pays, OOP max, and amount met.[10] ## Step-by-Step Application Process 1. **Visit Pfizer RxPathways**: Go to www.PfizerRxPathways.com, use the Program Finder, enter "Vyndaqel," and follow instructions.[1][2] 2. **Choose Method**: Online via **Pfizer PAP Connect** (upload docs, track status) or download/mail/fax paper form.[1][5][9] 3. **Gather Documents**: - Completed enrollment form (patient + prescriber sections).[4] - **Proof of income** (e.g., 1040 tax return pages 1-2, W-2, 2 pay stubs, SSA-1099).[2][4][10] - **Insurance info** (cards, denial letters if applicable).[8] - **Prescription** for Vyndaqel.[2] - **Patient authorization/signature** (affirm inability to pay).[3][10] 4. **Prescriber Completes Section**: Doctor confirms diagnosis, prescription, and insurance details.[4] 5. **Submit**: Online upload, mail to P.O. Box 66585, St. Louis, MO 63166-6585, or fax 866-470-1748 / 1-877-548-1734.[4][10] 6. **Phone Help**: Call (888) 222-8475 for support.[Provided] **Tip**: Use PAP Connect for faster processing and refills.[5][9] ## Timeline and Delivery - **Processing**: 2-3 weeks for enrollment decision notification.[1][4] - **Supply**: Up to 1 year for uninsured; 90 days for Medicaid applicants. **Reauthorization required** annually or per term.[Provided][2] - **Delivery**: Shipped free to your home or doctor's office.[Provided] ## Alternatives if Denied - **Appeal**: Contact Pfizer if income/docs issue; resubmit corrected info.[1] - **Other Programs**: Apply to Medicaid/State Exchange first if required.[2] Check NeedyMeds.org or RxAssist.org. - **Co-Pay Cards**: For commercial insurance via Pfizer Oncology Together (1-877-744-5675).[6][8] - **Patient Foundations**: PAN Foundation or HealthWell for ATTR-CM. - **Generic/Biosimilars**: None available for Vyndaqel.[Provided] - **Doctor Samples** or 340B clinics. ## Disclaimer This guide is for informational purposes only and based on available program details as of 2026. Eligibility, terms, and FPL levels can change—verify at PfizerRxPathways.com or call (888) 222-8475. Not medical/financial advice; consult your healthcare provider. Pfizer PAP rules subject to change without notice.[2]

Program information last verified: March 25, 2026